Cu entuziasm și profesionalism, Dr. Dan CĂLUGĂRU a format o echipă bine pregătită, care având la dispoziție tehnică medicală performantă, ajută la rezolvarea problemelor oftalmologice, punând întotdeauna accent pe confortul și siguranța pacienților, oferind servicii oftamologice complete la standarde înalte de calitate, atât prin experiența profesională cât și ca nivel al dotării cu aparatură. Echipa beneficiază de suportul și experiența Prof. Univ. Dr. Mihai Călugăru.
Re: Li et al.: Long-term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth Factor
October 2018, Volume 2, Issue 10, p. e13-e14
Published online: October 3, 2018
Guidelines on diabetic eye care. the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings
September 2018, Volume 8, Issue 9, pp.22645-22646
Published online: September 29, 2018
Vision Outcomes Following Anti–Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice
September 2018, Volume 193, p. 253–254
Published online: September 1, 2018
Comment on “Management strategies in malignant glaucoma secondary to antiglaucoma surgery”
August 2018, Volume 11, Issue 8, p. 1433-1434
Published online: August 7, 2018
What We Have Learned From the Ocular Hypertension Treatment Study
August 2018, Volume 192, p. 248–249
Published online: August 2, 2018
The fate of eyes with wet AMD beyond 4 years of anti-VEGF therapy
August 2018, Volume 256, Issue 8, pp 1551–1552
Published online: August 1, 2018
Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
July, 2018, Volume 10, Issue 7, pp.71192-71193
Published online: July 12, 2018
Sustained benefits from ranibizumab for central retinal vein occlusion with macular edema: 24-month results of the crystal study
July 2018, Volume 10, Issue 7, pp.71828-71829
Published online: July 11, 2018
Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management
July 2018, Volume 11, Issue 7, pp 1173-1178
Published online: July 10, 2018
Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success
July 2018, Volume 256, Issue 7, pp 1353–1354
Published online: June 19, 2018
Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
June 2018, Volume 256, Issue 6, pp 1209–1210
Published online: May 19, 2018
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
May 2018, Volume 256, Issue 5, pp. 1035–1037
Published online: May 2, 2018
Outcomes of Patients Initially Treated with Intravitreal Bevacizumab for Central Retinal Vein Occlusion: Long-Term Follow-Up
May 2018, Volume 33, Issue 3, p.318-319
Published online: May 1, 2018
Aflibercept for patients with neovascular age-related macular degeneration in routine clinical practice in Germany. Twelve-month outcomes of Perseus
April 2018, Volume 10, Issue 4, pp.68602-68603
Published online: April 23, 2018
Letter to the Editor: Ranibizumab 0.3 mg for Persistent Diabetic Macular Edema After Recent, Frequent, and Chronic Bevacizumab: The ROTATE Trial
March 2018, Volume 49, Issue 3, p. 160
Published online: March 21, 2018
Re: Khurana et al.: Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study (Ophthalmol Retina. 2017)
March 2018, Volume 2, Issue 3, p. e5–e6
Published online: March 2, 2018
Inner nuclear layer cystoid spaces are a poor prognostic factor in typical age-related macular degeneration and polypoidal choroidal vasculopathy
March 2018, Volume 256, Issue 3, pp. 627–629
Published online: March 1, 2018
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome
February 2018, Volume 186, p.164–165
Published online: Feb 1, 2018
Comments to: Restoration of photoreceptors in eyes with diabetic macular edema.
January 2018, Volume 28, Issue 1, pp. 132-133
Published online: January 5, 2018
Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy
January 2018, Volume 256, Issue 1, pp. 233–235
Published online: January 3, 2018
Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
January 2018, Volume 256, Issue 1, pp. 221–223
Published online: January 3, 2018
Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion
December 2017, Volume 184, p.190–191
Published online: December 1, 2017
Comments to: Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal
Nov-Dec 2017, Volume 27, Issue 6, pp. 627 - 800, e175 - e195
Published online: November 13, 2017
Correspondence
November 2017 - Volume 37 - Issue 11 - p e139–e141
Published online: November 11, 2017
Bun venit!
În clinica noastră se tratează peste 3000 de pacienți anual, număr în permanentă creștere, având în vedere progresul științific și tehnic de care echipa Dr. Călugăru este mereu preocupată.
Echipamentele noaste sunt furnizate de către producători consacrați în domeniu: Alcon (S.U.A), Bausch & Lomb (SUA), Blanco (Germania), Brumaba (Germania), Carl Zeiss Meditec (Germania), Spacelabs (S.U.A), Getinge (Suedia), Tomey (Japonia), Melag (Germania), Nidek (Japonia), Briot (Belgia).
Pentru operațiile de reducere a dioptriilor cu laser excimer (Lasek, Prk) nu este nevoie de analize. Pentru toate celelalte intervenții chirurgicale analizele sunt obligatorii.
Analizele necesare pentru operație:
- Hemoleucograma
- Coagulograma
- Glicemie
- Uree
- VSH
- AST
- ALT
- Bilirubina totală
- HVB
- HVC
- HIV
- Consult cardiologic
- EKG
Pentru a reuși vindecarea unui număr cât mai mare de pacienți echipa Dr. Călugăru colaborează cu mai mulți medici specializați în oftalmologie, opticieni și optometriști, cât și cu medicii de familie din zonele învecinate.